Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00582296 · ClinicalTrials.gov registry record

Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

A clinical trial of Lynch Syndrome, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
1,530
Enrollment target
8
Study locations

NCT00582296: Active study of Lynch Syndrome, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00582296 is a study of Lynch Syndrome that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,530 participants, below the 2,244-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (32% lower). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00582296, a study of Lynch Syndrome, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
1,530 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to examine how people with a family history of colon cancer and other related cancers respond to recommendations for cancer screening after genetic counseling. The purpose of your participation would be to help us learn more about whether people with a personal and/or family history of colorectal cancer and other cancers follow cancer screening recommendations.

Conditions Studied

Interventions

  • BEHAVIORAL questionnaires, telephone interview, optional blood drawn
  • BEHAVIORAL questionnaires, telephone interview and optional blood drawn

Study Locations (8)

New York

  • Memorial Sloan Kettering Cancer Center @ Commack (Consent Only) - Commack
  • Memorial Sloan Kettering Westchester (Consent Only) - Harrison
  • Memorial Sloan Kettering Cancer Center Hauppauge (Consent Only) - Hauppauge
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering Nassau (Consent only) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent Only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent Only) - Montvale

Trial Details

FieldValue
Enrollment Target 1,530 participants
Start Date 2004-12
Est. Completion 2026-12
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT00582296 still lists

NCT00582296 is an observational study that tracks outcomes without assigning an intervention. Its 1,530 participants enrollment target places it among the larger protocols in the corpus, below the 2,244-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (32% lower).

The record links to 1 condition, with Lynch Syndrome appearing as the primary indexed condition, and to 2 interventions - of which questionnaires, telephone interview, optional blood drawn is the first listed.

NCT00582296 lists 8 locations in 2 states (New York, New Jersey).

Frequently Asked Questions

What is clinical trial NCT00582296 about?

NCT00582296 is a clinical study titled "Multi-Organ Screening Recommendations in Patients With Lynch Syndrome". The purpose of this study is to examine how people with a family history of colon cancer and other related cancers respond to recommendations for cancer screening after genetic counseling. The purpose of your participation would be to help us learn more about whether people with a personal and/or fa...

What is the current status of trial NCT00582296?

This trial is currently active not recruiting. The enrollment target is 1,530 participants. The study started on 2004-12. Estimated completion is 2026-12.

What conditions does trial NCT00582296 study?

This clinical trial studies the following conditions: Lynch Syndrome.

What interventions are being tested in trial NCT00582296?

The interventions under investigation include: questionnaires, telephone interview, optional blood drawn (BEHAVIORAL), questionnaires, telephone interview and optional blood drawn (BEHAVIORAL).

Who is sponsoring clinical trial NCT00582296?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00582296 being conducted?

This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lynch Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00582296's enrollment target sits among peer trials

1,530 4th of 21 higher than 18 of 21 other Lynch Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lynch Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06393374 · 1,530 participants · Phase 3

    Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • NCT07114510 · 1,530 participants · NA

    Optimal Ventilation for Cardiac Arrest

  • NCT06623097 · 1,528 participants · NA

    Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study

  • NCT06257082 · 1,526 participants · NA

    Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00582296, the US trial registry maintained by the National Library of Medicine. NCT00582296 (large enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.